David Tsur, a director at Kamada Ltd, filed a statement of changes in beneficial ownership on September 17, 2026, reporting the sale of ordinary shares on September 14, 2026.
Key Highlights
- Reporting person: David Tsur, listed as a Director of Kamada Ltd (NASDAQ:KMDA).
- Shares sold: 22,827 ordinary shares disposed of on September 14, 2026, with transaction code "S".
- Sale price: $8.18 per share, described in the filing as a convenience conversion from NIS using the Bank of Israel exchange rate as of September 14, 2026.
- Remaining ownership: Following the transaction, Tsur directly beneficially owned 407,929 ordinary shares.
- Filing date: The statement was signed and filed on September 17, 2026.
Director Share Disposition at Kamada Ltd
According to the filing, David Tsur, who is identified as a director of Kamada Ltd, disposed of 22,827 ordinary shares on September 14, 2026. The transaction is recorded under code "S," indicating an open-market sale. The reported price of $8.18 per share reflects a currency conversion from Israeli New Shekels (NIS), with the filing noting that the figure "represents a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of September 14, 2026."
Kamada Ltd is an Israel-based biopharmaceutical company, and its ordinary shares trade on NASDAQ:KMDA. The filing shows that Tsur's direct beneficial ownership in the company stood at 407,929 ordinary shares after the reported sale was completed. No derivative securities transactions were reported in Table II of the filing. The filing was made by one reporting person, and the address listed for Tsur is in Rehovot, Israel.
What Was Disclosed
The filing reported a single open-market sale of 22,827 ordinary shares by Director David Tsur at a converted price of $8.18 per share on September 14, 2026, leaving him with direct beneficial ownership of 407,929 shares.



Please wait processing your request...